Page 4 - Professor Michel Revel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

iTolerance, Inc and Kadimastem Enter into Collaboration Agreement for Development of a Potential Cure for Type 1 Diabetes and Receive US $1 0 Million Grant from the BIRD Foundation

iTolerance, Inc and Kadimastem Enter into Collaboration Agreement for Development of a Potential Cure for Type 1 Diabetes and Receive US $1 0 Million Grant from the BIRD Foundation
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

United statesTel avivSusan robertsAsaf shiloniJenene thomasAnthony japourIsrael innovation authorityTolerance incTel aviv stock exchangeWeizmann institute of scienceBinational israel uChief executive officerHuman embryonic stem cellsProfessor michel revelProfessor emeritusMolecular genetics

Kadimastem Receives Approval of Patent Registration for Its Cell Selection and Enrichment Technology Used to Develop Its IsletRx Treatment for Diabetes in a Third Territory

/PRNewswire/ Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing treatments for ALS and diabetes, has been granted its third.

Tel avivAsaf shiloniCompany contactsWeizmann institute of sciencePrnewswire kadimastem ltdIsrael patent officeTherapeutics incTel aviv stock exchangeMust have communicationsImplant therapeuticsIsrael patentChief scientific officer professor michel revelHuman embryonic stem cellsProfessor michel revelProfessor emeritusMolecular genetics

Kadimastem Receives US Patent For Amyotrophic Lateral Sclerosis (ALS) Treatment

Kadimastem Receives US Patent For Amyotrophic Lateral Sclerosis (ALS) Treatment
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.

United statesTel avivHagit stavinskyAsaf shiloniTrademark officeCompany websiteWeizmann institute of scienceNews kadimastem ltdTel aviv stock exchangeMust have communicationsUnited states patentChief scientist professor michel revelSecurities lawHuman embryonic stem cellsProfessor michel revelProfessor emeritus

Kadimastem Receives US Patent For Amyotrophic Lateral Sclerosis (ALS) Treatment

Kadimastem Receives US Patent For Amyotrophic Lateral Sclerosis (ALS) Treatment

United statesTel avivHagit stavinskyAsaf shiloniTrademark officeCompany websiteWeizmann institute of scienceNews kadimastem ltdTel aviv stock exchangeMust have communicationsUnited states patentChief scientist professor michel revelSecurities lawHuman embryonic stem cellsProfessor michel revelProfessor emeritus

Kadimastem Receives US Patent For Amyotrophic Lateral Sclerosis (ALS) Treatment

Press release content from News Direct Corporation. The AP news staff was not involved in its creation.

United statesTel avivAsaf shiloniTrademark officeKadimastem ltdWeizmann institute of scienceTel aviv stock exchangeMust have communicationsUnited states patentChief scientist professor michel revelSecurities lawHuman embryonic stem cellsProfessor michel revelProfessor emeritusMolecular geneticsWeizmann institute